Ajmalicine
規格
483-04-5CAS番号
207-589-5EC番号
methyl (1S,15R,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,18-pentaene-19-carboxylateIUPAC名
C21H24N2O3化学式
352.4 g/mol分子量
Ajmalicine; Raubasine; 483-04-5; delta-Yohimbine; Tetrahydroserpentine; Ajmalicin; Circolene; Sarpan; Hydrosarpan; Rauvasan; Isoarteril; 4QJL8OX71Z; CHEBI:2524; methyl (1S,15R,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate; DTXSID60904151; NSC-72133; methyl (1S,15R,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo(11.8.0.02,10.04,9.015,20)henicosa-2(10),4,6,8,18-pentaene-19-carboxylate; RefChem:875181; DTXCID401332036; (19alpha)-16,17-didehydro-19-methyloxayohimban-16-carboxylic acid methyl ester; 207-589-5; Substance II; MFCD00042748; CHEMBL123325; methyl (1S,15R,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate; .delta.-Yohimbine; Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methylester, (19a)-; NSC 72133; 8063-17-0; Methyl (19alpha)-19-methyl-16,17-didehydro-18-oxayohimban-16-carboxylate; (4S,4aR,13bS,14aS)-methyl 4-methyl-4a,5,7,8,13,13b,14,14a-octahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizine-1-carboxylate; 16,17-Didehydro-19-methyloxayohimban-16-carboxylic acid methyl ester; EINECS 207-589-5; UNII-4QJL8OX71Z; ajmalicina; BRN 0097268; Cristanyl; Raubasine;; Vinceine;; rauwolfia alkaloid; Delta-Yohimbine;; Raubasine (DCF); Lamuran (TN); Tetrahydroserpentine;; Alkaloids, Rauwolfia; Ajmalicine (Standard); Spectrum_000775; Py-tetrahydroserpentine;; SpecPlus_000425; RAUBASINE [MI]; Prestwick0_000592; Prestwick1_000592; Prestwick2_000592; Prestwick3_000592; Methyl 16,17-didehydro-19alpha-methyl-18-oxayohimban-16-carboxylat; RAUBASINE [MART.]; PYTETRAHYDROSERPENTINE; RAUBASINE [WHO-DD]; Methyl (19-methyl-16,17-dehydro-18-oxa-3alpha,15alpha,19beta,20beta-yohimban-16-carboxylat); BSPBio_000464; KBioSS_001255; 4-27-00-07927 (Beilstein Handbook Reference); DivK1c_006521; SCHEMBL309914; SPBio_002683; BPBio1_000512; GTPL8746; MEGxp0_001818; orb1685425; orb1940249; orb3139383; SCHEMBL29408811; ACon1_001630; HY-N1919R; KBio1_001465; KBio2_001255; KBio2_003823; KBio2_006391; HY-N1919; MSK10232; BDBM50030612; EBC-83029; AKOS015895125; FR09934; Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-alpha)-; NCGC00016647-01; NCGC00016647-02; NCGC00016647-03; NCGC00016647-04; NCGC00016647-06; AC-20175; AS-35306; DA-70706; CAS-4373-34-6; CAS-6474-90-4; CS-0018230; NS00009801; T8044; C09024; D08470; EN300-7385816; Q412957; BRD-K83028735-001-01-6; BRD-K83028735-003-03-8; 19b-methyl-16-methoxycarbonyl-16,17-didehydro-oxayohimbane; methyl (19alpha)-19-methyl-16,17-didehydrooxayohimban-16-carboxylate; Methyl 19alpha-methyl-16,17-didehydro-18-oxayohimban-16-carboxylate; (19.ALPHA.)-16,17-DIDEHYDRO-19-METHYLOXAYOHIMBAN-16-CARBOXYLIC ACID METHYL ESTER; (19alpha)-16,17-Didehydro-19-methyl-oxayohimban-16-carboxylic acid methyl ester; Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-.alpha).-; (7aR,8S,11aS,12aS)-8-Methyl-5,6,7a,8,11a,12,12a,13-octahydro-7H-9-oxa-6a,13-diaza-indeno[2,1-a]anthracene-11-carboxylic acid methyl ester; AJN; methyl (1S,15R,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4(9),5,7,18-pentaene-19-carboxylate; methyl (4S,4aR,13bS,14aS)-4-methyl-4a,5,7,8,13,13b,14,14a-octahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizine-1-carboxylate別名
